Oklo Inc.

https://oklo.com

Oklo Inc. is an advanced fission technology company focused on developing and deploying fast fission power plants to provide clean, reliable, and affordable energy at scale. The company's mission includes establishing a domestic supply chain for critical radioisotopes and advancing nuclear fuel recycling to convert nuclear waste into clean energy. Oklo Inc. was founded in 2013 and is headquartered in Santa Clara, California.

Oklo's primary product is the Aurora powerhouse, a small modular reactor (SMR) or microreactor designed to generate between 1.5 and 75 megawatts of electricity. The company operates on an "owner-operator" or "power-as-a-service" model, providing electricity and heat through long-term power purchase agreements. Beyond energy generation, Oklo is actively involved in nuclear fuel recycling and the production of radioisotopes for various applications, including medical diagnostics and industrial uses. Oklo targets a diverse range of market segments, including data centers, artificial intelligence (AI) applications, industrial facilities, remote communities, and defense installations.

Oklo Inc. became a publicly traded company in May 2024 through a SPAC merger with AltC Acquisition Corp., trading on the NYSE under the ticker symbol OKLO. Co-founded by Jacob DeWitte (CEO) and Caroline DeWitte (COO), the company has recently engaged in notable collaborations, including a partnership with NVIDIA and Los Alamos National Laboratory to advance nuclear fuel validation for AI factories. Oklo has also secured agreements with major entities like Equinix and Meta Platforms for energy supply, underscoring its strategic market positioning in addressing growing energy demands with advanced nuclear solutions.

Latest updates

NRC Fast-Tracks Oklo’s Design Criteria Approval for Idaho Reactor

Event summary

  • NRC approved Oklo’s Principal Design Criteria topical report for Aurora powerhouse in Idaho on an accelerated schedule.
  • Review completed in less than half the traditional timeline, with acceptance notice in just 15 days.
  • Approval establishes regulatory framework for future reactor licensing and design activities.
  • Milestone aligns with NRC’s modernization efforts following 2025 executive orders and the ADVANCE Act.

The big picture

The NRC’s expedited approval of Oklo’s design criteria reflects growing federal support for advanced nuclear technologies. This milestone comes amid broader efforts to streamline licensing processes through the ADVANCE Act and 2025 executive orders, signaling a shift toward faster deployment of next-generation reactors. Oklo’s success in securing this approval could influence the regulatory pathway for other advanced fission projects, potentially accelerating the commercialization of clean energy solutions.

What we're watching

Regulatory Efficiency
Whether the NRC can sustain accelerated review timelines for other advanced reactor projects.
Deployment Pace
How quickly Oklo can leverage this approval to advance construction and licensing of the Aurora powerhouse.
Industry Precedent
Whether this approval sets a new standard for performance-based licensing in the U.S. nuclear sector.

Oklo Partners with NVIDIA, Los Alamos to Advance Nuclear-Powered AI

Event summary

  • Oklo, NVIDIA, and Los Alamos National Laboratory have formed a collaboration to advance nuclear fuel validation and AI-enabled research.
  • The partnership aims to combine Oklo’s sodium-fast-reactor platform, NVIDIA’s AI infrastructure, and LANL’s materials science expertise.
  • Initial efforts will focus on physics-based AI models for plutonium-bearing fuels and grid stabilization studies for nuclear-powered AI factories.
  • The project supports Oklo’s Pluto reactor development under the DOE’s Reactor Pilot Program and the Genesis Mission.

The big picture

This collaboration represents a significant convergence of advanced nuclear power and artificial intelligence, reflecting a broader trend towards leveraging AI to optimize complex industrial processes. The partnership's focus on plutonium-bearing fuels and nuclear-powered AI factories suggests a strategic bet on resilient, high-assurance energy solutions for critical infrastructure, potentially positioning Oklo to capitalize on growing demand for secure power sources. The involvement of Los Alamos National Laboratory underscores the government’s continued investment in advanced nuclear technologies.

What we're watching

Regulatory Hurdles
The success of this collaboration hinges on navigating the complex regulatory landscape surrounding advanced nuclear technologies and plutonium handling, which could significantly impact timelines and costs.
AI Integration
The ability to effectively integrate AI models into nuclear fuel validation and reactor operation will be crucial, and any limitations in data availability or model accuracy could impede progress.
Funding Risk
Continued funding from the DOE and private investors will be essential to sustain the project, and shifts in government priorities or market sentiment could jeopardize its long-term viability.

Oklo Bolsters Board, Management as Nuclear Ambitions Grow

Event summary

  • Oklo appointed four new directors: Dr. Mark Peters, David Christian, Derek Kan, and David Park, effective April 10, 2026.
  • Michael Thompson was appointed as Lead Independent Director, recognizing his experience in hypergrowth environments.
  • Oklo's Chief Technology Officer, Pat Schweiger, is transitioning to a senior technical advisory role.
  • The changes are intended to support Oklo's distinct business units focused on powerhouses, fuel, fuel recycling, and isotopes.

The big picture

Oklo's restructuring signals an acceleration of its ambitions in the advanced nuclear sector, reflecting the increasing complexity of its operations across power generation, fuel production, and isotope development. The addition of experienced directors from diverse industries suggests a need for enhanced operational expertise to navigate the challenges of scaling a nascent technology. This move also highlights the growing trend of specialized governance structures within companies pursuing disruptive technologies.

What we're watching

Governance Dynamics
The effectiveness of the new board composition in guiding Oklo's complex, multi-faceted business units remains to be seen, particularly given the diverse backgrounds of the appointees.
Execution Risk
The transition of the CTO to an advisory role introduces a risk of knowledge loss and disruption, and whether the remaining team can maintain the pace of innovation.
Regulatory Headwinds
The ability of Oklo to secure necessary regulatory approvals and licenses for its facilities will be a critical determinant of its success, and delays could significantly impact deployment timelines.

Blykalla Invests $100-200M in Oklo Partnership to Accelerate Fast Reactor Commercialization

Event summary

  • Oklo and Blykalla are expanding their transatlantic strategic partnership focused on fast reactor commercialization.
  • Blykalla plans to invest $100-200 million and deploy 30-40 engineers in the U.S. over the next several years.
  • Collaboration will include supporting Oklo’s DOE-authorized reactor pilot project and exploring fast-neutron irradiation testing.
  • Blykalla raised $50 million last year to accelerate the industrialization of its SEALER lead-cooled reactor.

The big picture

This partnership signals a growing trend of transatlantic collaboration in the advanced nuclear sector, driven by the increasing demand for carbon-free energy and the need to accelerate the deployment of next-generation reactors. Blykalla’s investment provides Oklo with crucial resources to advance its pilot project and fuel recycling technologies, but also underscores the capital-intensive nature of developing and commercializing advanced fission power. The move highlights the strategic importance of fast reactors in addressing global energy needs and potentially displacing traditional nuclear power generation.

What we're watching

Regulatory Hurdles
The success of this partnership hinges on navigating complex regulatory frameworks and securing necessary approvals from the DOE and NRC, which could introduce delays and cost overruns.
Execution Risk
Integrating Blykalla’s engineering resources and expertise into Oklo’s existing operations presents execution risks, particularly given the nascent stage of advanced fission technology.
Capital Needs
The $100-200 million investment from Blykalla represents a significant commitment, but Oklo will likely require additional capital to scale its operations and achieve commercial viability, potentially diluting existing shareholders.

Oklo CEO Joins Trump's Science Advisory Council

Event summary

  • Oklo CEO and co-founder Jacob DeWitte has been appointed to the President’s Council of Advisors on Science and Technology (PCAST).
  • DeWitte joins a council co-chaired by David Sacks and Michael Kratsios, alongside other tech and business leaders.
  • The PCAST advisory committee has existed since 1933, with each President establishing their own iteration.
  • Oklo, founded 13 years ago with Caroline DeWitte, is developing advanced fission power plants and fuel recycling technologies.

The big picture

Oklo’s CEO appointment to PCAST signals a potential shift in the administration’s focus on advanced nuclear technologies as a component of its energy strategy. This move could accelerate regulatory approvals and provide access to valuable policy insights, but also exposes the company to political risk and scrutiny. The appointment also highlights the growing importance of government-industry collaboration in the development of next-generation energy solutions, a trend likely to intensify as the energy transition accelerates.

What we're watching

Policy Influence
The extent to which DeWitte’s presence on PCAST will directly influence Oklo’s regulatory approvals and policy priorities remains to be seen, particularly given the politically charged nature of nuclear energy.
Market Perception
Whether this appointment will improve Oklo’s public image and investor confidence, offsetting concerns about the nascent nature of its technology and the long timelines for commercial deployment, warrants observation.
Strategic Alignment
How closely Oklo’s strategic direction aligns with the PCAST’s recommendations and the broader administration’s energy policy will be a key indicator of potential benefits and constraints.

Oklo Secures DOE Approval for Isotopes Test Reactor, Accelerating Advanced Nuclear Push

Event summary

  • Oklo’s Atomic Alchemy subsidiary received Nuclear Safety Design Agreement (NSDA) approval from the U.S. Department of Energy (DOE) for its Groves Isotopes Test Reactor.
  • The approval follows an Other Transaction Agreement (OTA) signed in January as part of the DOE’s Reactor Pilot Program (RPP).
  • The next phase involves submitting a Preliminary Documented Safety Analysis (PDSA) for DOE review.
  • Atomic Alchemy is targeting criticality for the Groves facility by July 4, 2026.
  • The facility is located within the Proto-Town Innovation Hub in Texas.

The big picture

The DOE’s Reactor Pilot Program represents a deliberate effort to accelerate the development of advanced nuclear technologies, moving beyond traditional regulatory frameworks. Oklo’s NSDA approval signals progress in this initiative, but the success of the Groves facility will be vital in demonstrating the scalability and economic viability of domestically produced isotopes, which are currently reliant on overseas suppliers and aging infrastructure. This facility’s performance will influence the broader adoption of advanced nuclear reactors and fuel recycling technologies.

What we're watching

Regulatory Scrutiny
The thoroughness of the DOE’s review of the Preliminary Documented Safety Analysis (PDSA) will be a key indicator of future project timelines and potential roadblocks.
Execution Risk
The ability of Atomic Alchemy to achieve criticality by the July 2026 target will be crucial for maintaining momentum and securing further DOE funding.
Commercialization Path
How the data and processes refined at the Groves facility translate into the licensing and deployment of subsequent commercial plants will determine the long-term viability of Oklo’s isotope production strategy.

Oklo Reports 2025 Results, Faces Regulatory and Funding Hurdles

Event summary

  • Oklo Inc. published its financial results and business update for the year ended December 31, 2025.
  • The company will host a conference call on March 17, 2026, featuring CEO Jacob DeWitte and CFO Craig Bealmear.
  • Oklo holds a site use permit from the U.S. Department of Energy and has received fuel from Idaho National Laboratory.
  • The company has submitted the first custom combined license application for an advanced reactor to the U.S. Nuclear Regulatory Commission.

The big picture

Oklo's progress represents a bet on the future of advanced nuclear energy, a sector facing both significant opportunity and substantial regulatory and financial hurdles. While the company has made early strides in securing permits and fuel, the long lead times and high costs associated with nuclear power development pose ongoing challenges. The company's ability to demonstrate commercial viability and attract further investment will be key to its long-term success.

What we're watching

Regulatory Headwinds
The success of Oklo's business model hinges on navigating the U.S. Nuclear Regulatory Commission's approval process, and delays or rejections could significantly impact timelines and costs.
Funding Risk
Given the capital-intensive nature of advanced nuclear technology, Oklo's ability to secure additional financing on favorable terms will be crucial for continued development and deployment of its powerhouses.
Execution Risk
The company's progress in developing fuel fabrication, radioisotope production, and fuel recycling facilities will determine its ability to achieve its stated goals and generate revenue.

Oklo Secures DOE Approval for Aurora Reactor Design at Idaho Lab

Event summary

  • Oklo Inc. signed a U.S. Department of Energy (DOE) Other Transaction Agreement (OTA) to support the Aurora powerhouse reactor at Idaho National Laboratory (INL).
  • The DOE approved the Nuclear Safety Design Agreement (NSDA) for the Aurora powerhouse, marking the first step in DOE’s Reactor Pilot Program (RPP) authorization licensing pathway.
  • Oklo has requested DOE to begin review of its Preliminary Documented Safety Analysis (PDSA).
  • The Aurora Fuel Fabrication Facility (A3F) at INL, which will fabricate fuel for Aurora-INL, previously received DOE approvals in November 2025 and December.

The big picture

This approval represents a significant milestone for Oklo, positioning it as a frontrunner in the emerging advanced nuclear sector. The DOE’s Reactor Pilot Program aims to revitalize U.S. nuclear industrial capacity, but the program's success is contingent on navigating complex regulatory frameworks and demonstrating the safety and scalability of these new reactor designs. Oklo's reliance on DOE oversight, while accelerating initial deployment, also creates dependency and potential for policy shifts.

What we're watching

Regulatory Headwinds
The success of Oklo’s accelerated licensing pathway hinges on the DOE’s continued commitment to the Reactor Pilot Program and its ability to avoid delays or shifts in regulatory philosophy.
Execution Risk
The integrated effort between the Aurora powerhouse and the Aurora Fuel Fabrication Facility requires tight coordination and presents a significant execution risk, particularly given the novel nature of the technology.
Commercialization
The transition from DOE authorization to NRC licensing will be critical for Oklo’s long-term commercial viability, and the timeline and potential conditions of that process remain uncertain.

Oklo Secures First NRC License, Advances Isotope Production

Event summary

  • Oklo Inc. subsidiary Atomic Alchemy received its first NRC materials license on March 17, 2026.
  • The license authorizes handling, processing, and distribution of up to 2 Curies of Ra-226, along with sealed sources of Co-60 and Am-241.
  • Atomic Alchemy’s Idaho Radiochemistry Laboratory will process isotopes, initially recovering material from disused radium sources.
  • The license supports Oklo’s plans for a multi-reactor isotope foundry with up to four 15 MWth Versatile Isotope Production Reactor (VIPR) systems.

The big picture

This license marks a significant step for Oklo, moving beyond design and planning into tangible execution within the nuclear sector. The increasing demand for isotopes, particularly for medical applications like targeted alpha therapy, highlights a strategic opportunity for domestic production to reduce reliance on foreign sources. Oklo’s entry into isotope processing positions it to benefit from a market currently constrained by limited U.S. supply chains and potentially high import costs.

What we're watching

Regulatory Headwinds
The speed of future NRC approvals for Oklo’s broader isotope production plans will be a key indicator of the company’s ability to scale operations and meet growing demand.
Execution Risk
The success of Atomic Alchemy’s processes and procedures, developed through laboratory experience, will be critical for the eventual deployment and efficiency of the planned isotope foundry.
Market Dynamics
How effectively Oklo can secure contracts and establish a reliable distribution network for its isotopes will determine its ability to capitalize on the rising demand and limited domestic supply.

Oklo, Centrus Plan Joint Venture to Build HALEU Deconversion Capacity

Event summary

  • Oklo and Centrus have agreed to pursue discussions for a joint venture focused on deconversion services for high-assay low-enriched uranium (HALEU).
  • The joint venture would be located at Centrus’ Piketon site in Ohio, co-located with enrichment operations and adjacent to Oklo’s planned 1.2 GW power campus.
  • The venture aims to improve efficiency and expand domestic advanced nuclear fuel capacity, addressing a potential bottleneck in HALEU deployment.
  • The collaboration aligns with broader redevelopment efforts to transform the former Portsmouth Gaseous Diffusion Plant into a clean energy hub.

The big picture

The planned joint venture represents a strategic move to address a critical gap in the U.S. nuclear fuel cycle, particularly for advanced reactor designs requiring HALEU. Currently, the lack of domestic deconversion capacity poses a significant risk to the broader nuclear energy sector’s growth. By co-locating enrichment and deconversion, the venture aims to reduce costs and improve efficiency, potentially accelerating the adoption of advanced nuclear technologies and strengthening U.S. energy security.

What we're watching

Regulatory Approval
The success of the joint venture hinges on securing regulatory approvals for co-location of enrichment and deconversion services, which could face scrutiny and delays.
Capital Allocation
The financial commitment required for the joint venture and associated infrastructure development could strain both Oklo and Centrus’ capital resources, impacting other strategic initiatives.
Market Demand
The venture’s viability depends on the pace of HALEU-fueled reactor deployment, and whether demand for deconversion services can sustain the investment in expanded capacity.

Meta Funds Oklo's Ohio Nuclear Project, Signaling Data Center Power Strategy

Event summary

  • Oklo Inc. has secured an agreement with Meta Platforms to prepay for power and fund the development of a 1.2 GW nuclear power campus in Pike County, Ohio.
  • The funding will be used to secure nuclear fuel and advance Phase 1 of Oklo’s Aurora powerhouse deployment.
  • The project is situated on 206 acres of land previously owned by the Department of Energy and facilitated by the Southern Ohio Diversification Initiative (SODI).
  • Construction and site characterization are planned to begin in 2026, with the first phase targeted for 2030 and full capacity by 2034.

The big picture

This agreement highlights a growing trend of hyperscale data center operators directly investing in power generation to ensure grid reliability and sustainability. Meta’s commitment to Oklo’s advanced nuclear project represents a significant bet on baseload power to support its AI infrastructure, and signals a willingness to fund infrastructure development beyond traditional power purchase agreements. The deal also underscores the potential for repurposing former government sites for clean energy initiatives, particularly in regions seeking economic revitalization.

What we're watching

Financial Risk
Whether Oklo can secure additional funding rounds beyond Meta’s commitment to complete the project, given the capital-intensive nature of nuclear power development.
Regulatory Approval
The pace at which Oklo obtains necessary regulatory approvals from the Nuclear Regulatory Commission (NRC) will dictate the project’s timeline and overall viability.
Grid Integration
How effectively the new power generation integrates with the PJM interconnection and whether transmission constraints will limit the project’s output.

Oklo Secures DOE Funding for Radioisotope Pilot Plant, Shelves Commercial Permit

Event summary

  • Oklo Inc. signed a U.S. Department of Energy (DOE) Other Transaction Agreement (OTA) to build a radioisotope pilot plant.
  • The facility will be constructed under the DOE Reactor Pilot Program (RPP).
  • Atomic Alchemy Inc., an Oklo subsidiary, will lead the pilot plant’s development.
  • Oklo has withdrawn its previously submitted Nuclear Regulatory Commission (NRC) construction permit for the Meitner-1 commercial facility to focus on the pilot plant.
  • The OTA marks a transition from planning to active execution for the project.

The big picture

The partnership highlights the U.S. government’s increasing focus on securing domestic supply chains for critical medical isotopes, currently reliant on foreign sources and aging infrastructure. Oklo’s strategy of prioritizing a pilot plant over immediate commercial deployment represents a shift towards a ‘learn-first’ approach, common in emerging nuclear technologies, but carries inherent risks. This move also signals a potential realignment within the advanced reactor sector, with government funding playing a more central role in de-risking early-stage projects.

What we're watching

Execution Risk
The success of the pilot plant hinges on Oklo’s ability to execute construction and operations under DOE authorization, which could be subject to delays and unforeseen challenges.
Regulatory Headwinds
While the pilot program aims to streamline regulatory processes, future commercialization will still require navigating complex NRC approvals, and the pilot’s data will be crucial in shaping those processes.
Commercialization Path
The long-term viability of Oklo’s radioisotope production strategy depends on the pilot plant’s ability to demonstrate a clear path to scalable, commercially viable production, justifying further investment.
CID: 579